Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer | Zendy

Aurelio Castrellon | Zendy; Michel Velez | Zendy; Steven Nguyen | Zendy; Marcelo Blaya | Zendy; S Barnick | Zendy; Katerine Dumais | Zendy; Nicholas LeCroy | Zendy; Luis E. Raez | Zendy

Open Access

Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer

Author(s) -

Aurelio Castrellon,

Michel Velez,

Steven Nguyen,

Marcelo Blaya,

S Barnick,

Katerine Dumais,

Nicholas LeCroy,

Luis E. Raez

Publication year - 2017

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2017.07.006

Subject(s) - medicine , anthracycline , epirubicin , carboplatin , regimen , chemotherapy , breast cancer , cyclophosphamide , triple negative breast cancer , oncology , gastroenterology , surgery , cancer , cisplatin

To evaluate the effectiveness and tolerability of neoadjuvant chemotherapy with weekly paclitaxel in combination with weekly carboplatin area under curve 2 followed by anthracycline chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research